STAT+

Pharmalot Ed Silverman

Despite court ruling, FDA will continue with its approach to approving orphan drug exclusivity

Pharmalot Ed Silverman

Pharmalittle: Obesity guidelines cause backlash; Bayer is pushed to spin off its consumer health business

Health Tech Casey Ross

As more never-smokers develop lung cancer, researchers test an AI model to predict patient risk

Hospitals Bob Herman

A different kind of ‘RAC’ subsidized hospitals’ labor during the pandemic

Biotech Allison DeAngelis

How one private biotech seized on JPM to emerge from stealth and tell its story

Biotech Ryan Cross — The Boston Globe

‘Holding on by its fingernails.’ The biotech industry in Massachusetts braces for another tough year

Pharmalot Ed Silverman

FTC wants ‘pharma bro’ Martin Shkreli held in contempt for violating lifelong ban on working in pharma

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalittle: FDA rejects Lilly application for Alzheimer’s drug; Sanofi offers a warranty for a medicine

Biotech Adam Feuerstein

FDA rejects Lilly’s bid for accelerated approval for its Alzheimer’s drug

Pharmalot Ed Silverman

‘A cascade of failures’: FDA cites Indian drugmaker for numerous quality control problems

Pharmalot Ed Silverman and John Wilkerson

Pallone pushes NIH and FDA to disclose steps being taken to ensure clinical trial results are reported

Pharmalot Ed Silverman

For only the second time, a big drugmaker offers a warranty on a medicine

Pharmalot Ed Silverman

Pharmalittle: India regulator finds 5% of drug samples are substandard; EMA claims new clinical trial registry is fixed

Exclusive Matthew Herper and Casey Ross

Verily leans into Onduo as it looks to enter the lucrative world of running medical research

Pharmalot Ed Silverman

Pharmalittle: HIV vaccine study is stopped early; Merck has a plan to combat carcinogen found in diabetes drugs

Business Tara Bannow

Hip and knee replacements go better when performed by high-volume surgeons, new study finds

Pharmalot Ed Silverman

Major purchasers predict expensive new therapies will keep driving drug price hikes

Biotech Matthew Herper

Moderna says RSV vaccine worked, setting stage for competition with GSK and Pfizer

Biotech Jason Mast

After four years of big talk, mega startup Sana prepares to deliver some data

Pharmalot Ed Silverman

Pfizer says it will widen access to hundreds of off-patent medicines in low-income countries

Pharmalot Ed Silverman

Pharmalittle: Lilly and AbbVie exit U.K. drug-pricing program; J&J scales back Covid-19 vaccine production

Pharmalot Ed Silverman

Large health insurers lowered barriers to fair access to some drugs, analysis finds

Opinions+ Christine Swisher and Gabriel Seidman

4 concrete steps to realize the AI Bill of Rights for clinical decision support software

Hospitals Bob Herman

Hospitals gear up to expand market power, raise prices in 2023

Biotech Jonathan Wosen

Liquid biopsy study suggests a better way to decide which colorectal cancer patients need chemo

Politics John Wilkerson

Congressional Medicare advisers warn of higher drug prices, despite new price negotiation

Health Tech Mohana Ravindranath

‘We’re no exception’: Why Carbon Health is changing course as economic pressures mount

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings